Juliette Berangere Audet serves as Executive at NewAmsterdam Pharma Co N.V., where they oversee executive responsibilities. Since joining the company, Juliette Berangere Audet has executed 1 insider transactions totaling $17.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 26, 2024 involved purchasing 1,104 shares valued at $17.3K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 26, 2024 | NAMS | $17.3K | Purchase | 1,104 | $15.70 | Discretionary |
Juliette Berangere Audet currently holds 1,104 shares of NewAmsterdam Pharma Co N.V. (NAMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Juliette Berangere Audet has been a net buyer of NAMS stock. They have purchased $17.3K and sold $0 worth of shares.
Juliette Berangere Audet's most recent insider trade was on Sep 26, 2024, when they purchased 1,104 shares at $15.70 per share.
Get notified when new Form 4 filings are submitted